article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Sodium-glucose transporter 2 (SGLT-2) inhibitors have been proved to decrease the cardiovascular adverse events in several large randomized controlled trials (RCTS), but evidence limited to patients with type 2 diabetes and ASCVD. Setting or Dataset Five electronic systems of community clinic.

article thumbnail

Patient Violence Travels Cross-Setting: From EMS to ED to Inpatient

Physician's Weekly

Research shows that patient violence spans care settings, starting in the out-of-hospital setting, continuing in the ED, and persisting into inpatient units. The analysis captured 206 violent out-of-hospital encounters, 868 violent ED encounters, and 3,561 violent non-ED hospital encounters involving 2,251 unique patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Maryland's Primary Care Program: incremental progress or breakthrough?

The Health Policy Exchange

Our residency, formerly a collaboration with Providence Hospital, is now known as the Medstar Health/Georgetown-Washington Hospital Center Family Medicine Residency Program. - Kenny Lin, MD, MPH Much has changed in the past six years since our last Health Policy Journal Club at Georgetown. I stepped down as director of the Robert L.

article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

Cardiovascular Events The SELECT trial 1 randomized 17,604 patients with preexisting CVD and overweight/obesity. Relative risk for cardiovascular events was reduced by 19% (RRR), while the absolute risk was reduced by 1.5% 5 In March 2024, Novo Nordisk announced that 24% less CKD-related events occurred in the intervention group.

Diabetes 130
article thumbnail

Q&A: Can Digital Inhalers Predict Exacerbations of COPD?

Physician's Weekly

Exacerbations often result in hospitalizations or long-term lung function decline, and existing remote monitoring tools fall short in capturing physiologic changes specific to lung function. Could those alerts integrate directly into electronic health records? Is there a chance you’re having an exacerbation? That’s the next step.

article thumbnail

Didn’t Match into Residency.What are Some of my Options?

Aspiring Minority Doctor

In the event you are unsuccessful at extending your graduation date or securing an internship position, options for practicing medicine tend to become severely limited. After extending your graduation date, the year can be utilized as a research year that can help you enhance your application and build further connections.

GP 52
article thumbnail

As the Calendar Turns, Cybersecurity Remains Key Focus of Digital Health Enforcement

FDA Law

But a compromised device is a threat to patient safety, so that timeline that could change in the event of an adverse event that imperils consumer health. Until that happens, interested parties in this space continue to face many of the same cybersecurity threats as other data-tech entities.